Moderna’s mRNA Flu Vaccine Back Under FDA Review THURSDAY, Feb. 19, 2026 (HealthDay News) — In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine. Full Article